Sign up for the new Critical Metals Report newsletter!

(6/7/11)

Regeneron Reports Positive Phase 3 Dupixent Data; Gains EU Approval Recommendation
Source: Streetwise Reports (09/20/2019)

Regeneron Pharmaceuticals published positive results from two U.S. Phase 3 trials evaluating the safety and efficacy of Dupixent (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps. The European Medicines Agency's Committee for Medicinal Products for Human Use also adopted a positive opinion for Dupixent in a third indication.

SunPower's Energy Storage Reflecting Well on Its Shares
Source: Streetwise Reports (09/19/2019)

SunPower Corp. shares traded 6% higher as the firm announced that its Equinox Storage paired with its platform provides energy independence to residential users.

Small-Cap's Large Solar Project in Puerto Rico Moves Closer to Fruition
Source: Streetwise Reports (09/19/2019)

The support of the Puerto Rico Financial Oversight and Management Board advances the solar project.

FedEx Shares Down 13.5% on Earnings and Global Trade Concerns
Source: Streetwise Reports (09/18/2019)

FedEx Corp. shares traded lower after it reported Q1/20 earnings. The firm confirmed it will raise prices by 4.9% to 5.9% in January 2020.

Apogee Enterprises Shares Trade Up 12.5% on Q2 Earnings and Yearly Outlook
Source: Streetwise Reports (09/17/2019)

Shares of Apogee Enterprises traded higher after the commercial and architectural glass and framing company announced Q2/20 earnings and updated its estimates for the rest of the year.

Explorer Eagerly Awaits Results of Summer Drill Program in Prolific Quebec Mining Area
Source: Streetwise Reports (09/17/2019)

Property receives first drilling in more than a decade.

Alder BioPharmaceuticals Shares Surge 80% on Acquisition News
Source: Streetwise Reports (09/16/2019)

Shares of migraine treatment research firm Alder BioPharmaceuticals soared 84% after the company announced that it has agreed to be acquired by H. Lundbeck for $1.95 billion.

Fibrocell Science Shares Rise 60% on Acquisition News
Source: Streetwise Reports (09/13/2019)

Fibrocell Science's shares traded up 60% after the company announced that it agreed to be acquired by Castle Creek Holdings for $63.3 million, or $3.00 per share.

Moderna Shares Rise on the Release of Positive Results from Two mRNA Phase 1 Programs
Source: Streetwise Reports (09/12/2019)

Shares of Moderna Inc. traded up double-digits as the firm announced results from its Phase 1 CMV Vaccine Study as well as its Phase 1 data for mRNA-1944 encoding for antibody against the chikungunya virus.